NeoDiagnositx, Inc. Announces issuance of Expanded US Patent Portfolio
October 22, 2014
NeoDiagnostix announced that the United States Patent and Trademark Office has granted two new patents owned by the company (US Patent No. 8,748,099 and 8,852,865) covering the detection of chromosomal abnormalities in cervical samples. The recently issued patents cover methods for identifying chromosomal abnormalities at multiple sites of the genome, including loci 3q, 5p, 20q and/or 1q, in a plurality of cells from a cervical sample.

NeoDiagnostix Inc. Announces Issuance of Third US Patent
June 12, 2014
NeoDiagnostix, Inc. announced that the United States Patent and Trademark Office has issued US Patent No. 8,748,099 covering the detection of chromosomal abnormalities in cervical samples. The patent covers methods for enumerating chromosomal copy number at location 3q, as well as other loci in the genome of cells from cervical samples.